预览加载中,请您耐心等待几秒...
1/3
2/3
3/3

在线预览结束,喜欢就下载吧,查找使用更方便

如果您无法下载资料,请参考说明:

1、部分资料下载需要金币,请确保您的账户上有足够的金币

2、已购买过的文档,再次下载不重复扣费

3、资料包下载后请先用软件解压,在使用对应软件打开

临床医学临床医学研究与实践2021年4月第6卷第12期磷酸奥司他韦治疗小儿流行性感冒的临床效果康永桂1,刘维娜2*(1.咸阳市妇幼保健院,陕西咸阳,712046;2.宝鸡市第三人民医院,陕西宝鸡,721004)摘要:目的观察磷酸奥司他韦治疗小儿流行性感冒(流感)的临床效果。方法选取2017年11月至2019年3月我院收治的300例流感患儿作为研究对象,按照随机数字表法将其分为对照组和观察组,各150例。对照组给予抗感颗粒治疗,观察组给予磷酸奥司他韦治疗。比较两组患儿的治疗效果。结果观察组的治疗总有效率明显高于对照组(P约0.05)。治疗后,两组发热、咽喉痛、咳嗽、鼻塞流涕评分均较治疗前降低,且观察组低于对照组(P约0.05)。治疗后,两组的NEU%、WBC均较治疗前降低,且观察组低于对照组(P约0.05)。治疗后,两组的CRP、TNF-琢水平均较治疗前降低,CD3+、CD4+均较治疗前升高,且观察组优于对照组(P约0.05)。观察组的不良反应总发生率低于对照组(P约0.05)。结论磷酸奥司他韦治疗小儿流感效果显著,可有效缓解临床症状,改善外周血象及免疫功能,降低炎症因子水平,且用药不良反应少。关键词:磷酸奥司他韦;小儿;流感中图分类号:R97文献标志码:A文章编号:2096-1413(2021)12-0092-03ClinicaleffectofoseltamivirphosphateinthetreatmentofchildrenwithinfluenzaKANGYonggui1,LIUWeina2*(1.XianyangMaternalandChildHealthHospital,Xianyang712046;2.BaojiThirdPeople'sHospital,Baoji721004,China)ABSTRACT:ObjectiveToobservetheclinicaleffectofoseltamivirphosphateinthetreatmentofchildrenwithinfluenza.MethodsAtotalof300childrenwithinfluenzaadmittedinourhospitalfromNovember2017toMarch2019wereselectedastheresearchobjectsanddividedintocontrolgroupandobservationgroupaccordingtorandomnumbertablemethod,with150casesineachgroup.Thecontrolgroupwastreatedwithkanggangranule,andtheobservationgroupwastreatedwithoseltamivirphosphate.Thetherapeuticeffectsofthetwogroupswerecompared.ResultsThetotaleffectiverateoftreatmentintheobservationgroupwassignificantlyhigherthanthatinthecontrolgroup(P<0.05).Aftertreatment,thescoresoffever,sorethroat,cough,nasalcongestionandrunnynoseinthetwogroupswerelowerthanthosebeforetreatment,andthoseintheobservationgroupwerelowerthanthecontrolgroup(P<0.05).Aftertreatment,NEU%andWBCinthetwogroupswerelowerthanthosebeforetreatment,andthoseintheobservationgroupwerelowerthanthecontrolgroup(P<0.05).Aftertreatment,thelevelsofCRPandTNF-琢inthetwogroupswerelowerthanthosebeforetreatment,whileCD3+andCD4+werehigherthanthosebeforetreatment,andthoseintheobservationgroupwerebetterthanthecontrolgroup(P<0.05).Thetotalincidenceofadversereactionsintheobservationgroupwaslowerthanthatinthecontrolgroup(P<0.05).ConclusionOs